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ABSTRACT
Painful Diabetic Neuropathy (PDN) is a common complication of diabetes mellitus (DM). 
Disruption in presynaptic inhibition in dorsal horn of the spinal cord has been proposed as 
one of the pathomechanism of PDN. Previous research showed that presynaptic inhibition 
can be detected by H-reflex examination. The aim of this study was to know whether the 
reduction of presynaptic inhibition in spinal dorsal horn of PDN patients really exist, and 
detectable by H-reflex examination. It was cohort prospective involving 141 (58 men, 83 
women) patients with DM and impaired glucose tolerance (IGT) between the ages of 40 
and 61 years from several health facilities in Yogyakarta. All patients underwent clinical, 
laboratory and electrodiagnostic examination. Demographic, clinical and electrodiagnostic 
data were collected and analyzed. By survival analysis there were 25 new cases of 
PDN (12.12% cumulative incidence). Using survival Kaplan Meier analysis, the significant 
hazard ratio for PDN were 12.81 for median motor nerve amplitude, 5.74 for median 
nerve distal latency, 3.71 for median sensory nerve amplitude, 6.33 for median sensory 
latency, 3.4 for tibial nerve amplitude, 3.48 for tibial nerve distal latency, 2.29 for sural 
nerve amplitude, 4.47 for sural nerve latency, 3.99 for H-reflex latency, 5.88 for H-reflex 
amplitude, and 17.83 for Diabetic Neuropathy (DN) status. Using hazard proportional cox 
analysis, only H amplitude and DN status (DNS score) were significantly correlated with 
PDN (p= 0.026; hazard ratio = 15.450; CI 95%= 1.39 – 171.62 for H amplitude and 
p= 0.030; hazard ratio = 10.766; CI 95%=1.26 – 92.09 for DN status). 
This study showed that depression of H-reflex amplitude was correlated with the 
occurrence of PDN. This result proves that there was presynaptic inhibition process in 
PDN that manifests as low H-reflex amplitude.
ABSTRAK
Nyeri neuropati diabetik (PDN) merupakan suatu komplikasi yang umum pada 
diabetes mellitus (DM). Gangguan pada penghambatan presinaptik pada bagian 
dorsal horn dari sumsum tulang belakang diduga menjadi salah satu patomekanisme 
dari PDN. Penelitian sebelumnya menunjukkan bahwa penghambatan presinaptik 
dapat dideteksi dengan pemeriksaan H-refleks. Tujuan dari penelitian ini adalah 
untuk mengetahui apakah pengurangan inhibisi presinaptik di dorsal horn tulang 
belakang pasien PDN benar-benar ada, dan terdeteksi oleh pemeriksaan H-refleks. 
Penelitian ini adalah kohort prospektif yang melibatkan 141 (58 laki-laki, 83 perempuan) 
pasien DM dengan gangguan tolerasi glukosa berumur antara 40 sampai 61 tahun di 
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INTRODUCTION
Painful Diabetic Neuropathy (PDN) is a 
common complication of diabetes mellitus 
(DM), which can give large burdens because 
of its high incidence, serious clinical, 
economical and social impact and its 
unsatisfying treatment.1,2 
Biological process in spinal dorsal horn 
has been shown to have an important role in 
pathophysiology of PDN. Gate mechanism in 
the dorsal horn of the spinal cord plays a role 
by inhibiting or facilitating the flow of afferent 
impulses from peripheral nerves to the spinal 
cord before it evokes pain perception.3 Many 
research have shown that diminished synaptic 
inhibition plays a key role in neuropathic pain 
development.4 Normally, GABAA receptors in 
primary afferent terminals of nociceptors will 
mediate this presynaptic inhibition by causing 
reduction of transmitter release thus modulating 
the afferent input from dorsal root ganglion 
neurons into nociceptive projection neurons 
(presynaptic inhibition).4 In PDN this process 
was disturbed, leading to neuropathic pain.5 
berbagai rumah sakit di Yogyakarta. 
Semua pasien menjalani pemeriksaan klinis, laboratorium dan pemeriksaan 
elektrodiagnostik. Data demografi, klinis dan electrodiagnostic dikumpulkan dan dianalisis. 
Berdasarkan analisis survival ada 25 kasus baru PDN (kejadian kumulatif 12,12%). Dengan 
menggunakan analisis survival Kaplan Meier, Rasio hazard yang signifikan untuk PDN adalah 
12,81 untuk median amplitudo saraf motorik, 5.74 untuk median latensi distal saraf, 3,71 
untuk median amplitudo saraf sensorik, 6.33 untuk median latensi sensorik, 3,4 untuk 
amplitudo tibialis saraf, 3,48 untuk latensi saraf tibialis distal, 2,29 untuk amplitudo saraf 
sural, 4,47 untuk latensi saraf sural, 3,99 untuk latensi H-refleks, 5,88 untuk amplitudo 
H-refleks, dan 17,83 status Diabetes Neuropati (DN). Dengan menggunakan analisis cox 
proporsional hazard, hanya amplitudo H dan status DN (skor DNS) yang secara signifikan 
berkorelasi dengan PDN (p= 0,026; rasio hazard= 15,450; CI 95%= 1,39-171,62 untuk 
amplitudo H dan p= 0,030; rasio hazard= 10,766 ; CI 95%= 1,26-92,09 untuk status 
DN). Penelitian ini menunjukkan bahwa depresi amplitudo H-refleks berkorelasi dengan 
terjadinya PDN. Hasil ini membuktikan bahwa ada proses penghambatan presinaptik di 
PDN yang bermanifestasi pada rendahnya amplitudo H-refleks.
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H-reflex is an electrically induced reflex 
analogous to the mechanically induced spinal 
stretch reflex.6 The H-reflex bypasses the 
muscle spindle. Therefore, it is a valuable 
tool in assessing modulation of monosynaptic 
reflex activity in the spinal cord.6 The H-reflex 
is an estimate of alpha motoneuron (aMN) 
excitability when presynaptic inhibition and 
intrinsic excitability of the aMNs remain 
constant. This measurement can be used to 
assess the responsiveness of the nervous 
system to various neurologic conditions 
including pain7, hence H-reflex amplitude can 
be proposed as a method to assess presynaptic 
inhibition in humans. 
The aim of this study was to know whether 
the reduction of presynaptic inhibition in 
spinal dorsal horn of PDN patients really 
exist, and detectable by H-reflex examination. 
SUBJECTS & METHODS
The design of this study was cohort 
prospective. The inception cohort was 
diabetes mellitus patients free from PDN (ID 
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study of upper and lower extremity, and 
soleus H-reflex study were done at week 1. 
Nerve conduction study and H-reflex were 
conducted using an MEB-2300K ENMG 
machine (Nihon Kohden, Tokyo, Japan). The 
evaluation and record of PDN occurrence 
were carried out every week up to 12 months 
by self-assessment, monitored by the doctors. 
The Kaplan Meier survival analysis 
was conducted to see the ability of several 
electrodiagnostic variables to predict the 
possibility of subjects to suffer from PDN during 
the observation period. For this reason, the ID 
pain was measured periodically every 2 weeks, 
to assess the PDN status of the subjects. The data 
analyses were presented in TABLE of Kaplan 
Meier analysis, hazard ratio, and survival curve.
RESULTS
One hundred and forty one subjects (58 
men, 83 women) with an average age of 51 
years old (range, 40–61 years old), were 
enrolled in this study. Sixty five percent of the 
subjects were found to be diabetic, while the 
other 35% were found to have IGT. The mean 
glucose level was 116 mg/dl (range, 78 - 200 
mg/dL) for fasting, 170 mg/dL for 2 hours 
post prandial (range, 90 – 250 mg/dL). 
Screening by NSS and DNS scores at 
admission found that 57 subjects (40.4%) 
were diagnosed as neuropathy (Diabetic 
Neuropathy/DN) according to NSS, while 
68 (48.2%) were diagnosed as neuropathies 
according to DNS. There were no subjects 
diagnosed as PDN. However, upon completion 
of 48 weeks of observation, there were 12.12% 
cumulative incidence rate of PDN. 
Pain score below 2), followed by a 12-months 
disease follow-up. The protocol was approved 
by the Research Ethics Committees of Faculty 
of Medicine, Universitas Gadjah Mada, 
and all subjects were provided with written 
informed consent. The subjects of this study 
were patients at diabetes outpatient clinic 
Dr Sardjito Hospital Yogyakarta, members 
of diabetes association (Persatuan Diabetes 
Indonesia, PERSADIA) PKU Hospital 
Yogyakarta, staffs of STIKES Aisiyah 
Yogyakarta and the subjects from Pre-diabetic 
Research of Clinical Pathology Department at 
Dr Sardjito Hospital Yogyakarta.
The inclusion criteria were men and 
women 20 to 60 year-old, with type 2 diabetes 
mellitus or impaired glucose tolerance (IGT), 
as defined by American Diabetes Association 
(ADA) criteria. The exclusion criteria were 
anatomical deformities on extremities that 
would interfere with electrodiagnostic 
study protocol; pregnancy or lactation; a 
documented history of lumbosacral surgery 
that would interfere with electrodiagnostic 
study protocol; other diseases known to 
be associated with pain, especially chronic 
pain in the feet that the investigator believed 
would interfere with the assessment of pain 
associated with diabetic neuropathy, like 
cancer pain, lumbosacral abnormality or 
other entrapment neuropathy; and any acute 
or underlying serious illness that are likely 
interfere with completion of the trial .
Clinical and electrodiagnostic examinat-
ions were peformed in all patients. Baseline 
assessments, consisted of ID pain, neuropathy 
symptom score (NSS), diabetic neuropathy 
symptom (DNS), review of nerve conduction 
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The low amplitude of median and tibial 
nerve had significant value in predicting PDN 
occurence with hazard ratio 12.81 for median 
nerve amplitude (95% CI 1.69 – 96.10, p= 
0.01) and 3.4 for tibial nerve amplitude (95% 
CI 1.18 – 9.78, p= 0.02), while sural nerve 
with hazard ratio 2.29 was not significant 
(95% CI 0.85 – 6.16, p= 0.10). Distal latency 
of median, tibial, and sural nerve were also 
related significantly with PDN occurrence 
with hazard ratio 5.74 for median nerve (95% 
CI 1.63 – 20.13, p= 0.01), 3.48 for tibial nerve 
(95% CI 1.18 – 9.78, p= 0.02), and 4.74 for 
sural nerve latency (95% CI 1.72 – 13.04, 
p<0.001). Median nerve sensory amplitude 
and sensory latency were also significant with 
hazard ratio 3.71 (95% CI 1.06 – 13.01, p= 
0.04) and 6.33 (95% CI 2.20 – 18.24, p<0.001), 
respectively. Beside sural nerve amplitude, 
TABLE 1. Hazard ratio of PDN factor
HR p CI 95%
Median
Amplitude 12.81 0.01 1.69 – 96.10
Distal latency 5.74 0.01 1.63 – 20.13
Nerve Conduction 
Velocity
2.39 0.09 0.89 – 6.41
Sensory amplitude 3.71 0.04 1.06 – 13.01
Sensory latency 6.33 <0.001 2.20 – 18.24
Tibial
Amplitude 3.40 0.02 1.18 – 9.78
Distal latency 3.48 0.01 1.30 – 9.35
NCV 1.13 0.81 0.42 – 3.041
Sural
Amplitude 2.29 0.10 0.85 – 6.16
Latency 4.74 <0.001 1.72 – 13.04
H-reflex
Latency 3.99 0.03 1.14 – 14.00
H Amplitude 5.88 0.01 1.67– 20.63
Hyperglycemic status 45.34 0.07 0.71 – 2897.64
DN 17.83 0.01 1.63 – 20.14
the nerve conduction velocity of median nerve 
(hazard ratio= 2.39) and tibial nerve (hazard 
ratio= 1.13) were not significant.
The hazard ratio for H-reflex latency was 
3.99 (95% CI 1.14 – 14.00) and for H-reflex 
amplitude was 5.88 (95% CI 1.67 – 20.63). 
These variables were also significantly related 
to PDN occurrence with p value 0.03 and 0.01 
respectively. Beside the electrodiagnostic 
variables, the clinical variables were also 
measured. The status of DN with hazard ratio 
17.83 (95% CI 1.63 – 20.14, p= 0.01) was 
significantly related to the occurence of PDN, 
while the hyperglycemic status had high 
hazard ratio (45.43) but was not significant 
(95% CI 0.71 – 2897.64, p= 0.07). 
This analysis showed that neuropathy 
status (clinical and electrodiagnostic), was 
closely related to PDN occurrence.
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All variables that were significant in 
Kaplan Meier analysis were compared using 
Cox regression analysis. This analysis showed 
that only H-reflex amplitude and DN status 
(measured by DNS score) were significantly 
related to PDN occurrence. The hazard ratio 
for H-reflex amplitude was 15.450 (95% CI 
1.39 – 171.62, p= 0.026), and for DN status 
was 10.766 (95% CI 1.26 – 92.09, p= 0.030). 
Despite of the widened confidence interval, 
H-reflex amplitude had the highest hazard 
ratio among the other predictor variables. 
This result proved that there was presynaptic 
inhibition process in PDN that manifested as 
low H-reflex amplitude.
DISCUSSION
The study population in this research was 
patients with abnormality in blood glucose 
level (DM or IGT). After observation for 
almost 12 months, 40% of patients had 
neuropathy and 12% had PDN. Demographic 
data showed that hyperglycemic and 
neuropathic status significantly predict PDN. 
This result inherent to mechanisms proposed 
TABLE 2. Analysis of PDN Survival Cox regression
Variable Parameter P HR CI 95%
H-reflex H Amplitude 0.026 15.450 1.39 – 171.62
DN Status DNS score 0.030 10.766 1.26 – 92.09
H-reflex Latency 0.764 0.783 0.16 – 3.88
Median
Distal latency 0.458 1.736 0.40 – 7.45
NCV 0.763 0.836 0.26 – 2.68
Sensory 
Amplitude 
0.699 0.757 0.18 – 3.10
Sensory latency 0.136 2.942 0.71 – 12.16
Tibial
Amplitude 0.179 0.311 0.06 – 1.71
Distal latency 0.159 2.528 0.70 – 9.18
Sural
Sensory 
Amplitude 
0.293 0.499 0.14– 1.82
Sensory latency 0.973 1.030 0.19 – 5.62
by Fink and Oaklander8 that disruption of nerve 
function as a result of glucose accumulation 
in the nerve include abnormal metabolic 
product formation and focal tissue ischemia 
in sensory and autonomic nerves as a result 
of endoneural hypoxia. The excess of glucose 
and oxidative stress, aberrant neurofilament 
phosphorylation, disruption of normal nerve 
growth factors and mitochondrial dysfunction 
in the dorsal root ganglia, disturb normal 
function of tissue repair mechanisms.8
This study found that several variables of 
NCS were significantly related to PDN. Long-
term changes are likely occur after injury, 
both peripherally and centrally.9 Because NCS 
basically evaluates peripheral nerves, these 
positive results indicate the likelihood that 
peripheral nerve abnormality has contribution 
in PDN development. According to Zhuo,9 the 
injury and injury-related areas undergo long-
term plastic changes resulting in significantly 
enhanced pain sensation (hyperalgesia) or 
misinterpretation of non-noxious stimuli as 
pain (allodynia). Unlike physiological pain, 
pathological pain happens only after injury 
(e.g., tissue or nerve injury), and is not a result 
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FIGURE 1.  Survival diagram of PDN occurence from several predictor variables (the abnormality of tibial nerve 
conduction velocity, H-reflex latency, sural amplitude, and H-reflex amplitude).
of repetitive application of physiological 
pain.9
One of the reasons why so many changes 
happen following a nerve injury is that sensory 
neurons, and the non-neural cells associated 
with them, are highly interdependent in 
generating pain.10 The molecular mechanisms 
of pain generation in PDN are multifactorial 
and not fully understood. The predominantly 
involved is distal axon. This is related to the 
dependence of distal axon upon oxidative 
metabolism to sustain axonal transport. 
Disruption in the supply of blood, oxygen, 
glucose, ATP, or NADPH will disturb the 
transport, which will lead to distal axonal 
degeneration.8 
Analysis using Kaplan Meier survival in 
this study showed that H latency and amplitude 
are related to hazard ratio and the p value. 
H-reflex represents activity of peripheral and 
central nervous system. Therefore, our result 
indicated that there was probably abnormal 
function in the central region (dorsal horn 
of the spinal cord) which contributes 
to the generation of PDN. Gate control 
theory proposed that normal processing of 
nociceptive and non-nociceptive stimuli 
relies on a complex processing which consists 
of presynaptic and postsynaptic inhibitory 
control mechanism in the spinal dorsal horn. 
Under healthy condition, this inhibition is 
responsible in keeping the nociceptive and 
non-nociceptive modalities apart. The loss 
of this inhibition process has been widely 
accepted to lead to chronic pain. Blockade of 
this inhibition mechanism has been shown to 
cause hyperalgesia and tactile allodynia, two 
major symptoms of chronic pain. This has 
been supported by many research showed 
decrease in inhibition, or ‘‘disinhibition’’, 
as an important substrate of many chronic 
pain models.4 This disinhibition will result 
in increasing neurons excitability and enable 
excitatory input from non-nociceptive fiber to 
nociceptive projection neurons.4 
This is a part of a process called central 
sensitization, which arises after a chronic 
pain. Central sensitization is an enhancement 
in the functional status of neurons and 
circuits in nociceptive pathways caused by 
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increases in membrane excitability, synaptic 
efficacy, or a reduced inhibition in dorsal horn 
neurons in response to nociceptor input.11 
Sensitization of dorsal horn neurons occurs 
after various types of tissue damage including 
thermal injury, chemical injury, polyarthritis 
or after stimulation of C-fiber afferents.12 
After peripheral nerve injury, damaged and 
nondamaged A- and C-fibers begin to generate 
spontaneous action potentials which will 
drive central sensitization.11 Repeated C-fiber 
afferent stimulation also produces a sequential 
increase in dorsal horn activity resulting in a 
prolonged discharge of the cell (wind-up).12 
The stimuli that induce wind-up can lead to 
central sensitization.11
Structural changes in peripheral nerve 
injury also contribute to altered synaptic 
function. Peripheral nerve injury leads to 
a transganglionic degeneration of C-fiber 
terminals in lamina II.11 This will deprive 
pain transmission neurons in the superficial 
dorsal horn of their normal nociceptive input, 
and causes patients to experience negative 
symptoms.13 There will be increases in the 
intrinsic axonal growth capacity as part of the 
regenerative response of the injured neurons, 
which will result in sprouting of myelinated 
A-β fibers from lamina III-IV into lamina I-II 
and make contact with nociceptive-specific 
neurons.11 As a result, stimulation of low 
threshold mechanoreceptors abnormally 
activates pain transmission neurons in lamina 
II of the spinal cord.13
Diminished synaptic inhibition has also 
been acknowledged to have a key role in 
neuropathic pain development.5 Normally, 
GABAA receptors in primary afferent 
terminals of nociceptors will mediate this 
presynaptic inhibition by causing reduction 
of transmitter release thus modulating the 
afferent input from dorsal root ganglion 
neurons into nociceptive projection neurons 
(presynaptic inhibition).4 In PDN this pre-
synaptic inhibition was disturbed, which 
ultimately caused neuropathic pain. This 
disinhibition in the superficial dorsal horn 
is caused by the loss of GABAergic and a 
reduction in glycinergic inhibitory currents. 
Apoptosis of inhibitory interneurons, caused 
by NMDAR-induced cytotoxicity, has been 
proposed as the cause of this disinhibition.11
Presynaptic inhibition constitutes an 
inhibitory mechanism associated with 
modulation of monosynaptic reflexes. There-
fore, examination of monosynaptic reflex 
should be able to detect this pre-synaptic 
inhibition. One of the proposed methods is by 
assessing H-reflex. Our result showed that this 
presynaptic inhibition can indeed be assessed 
by H-reflex. The H-reflex is evoked by low-
intensity electrical stimulation of the afferent 
nerve resulting in monosynaptic excitation 
of α-motoneurons. Changes in the amount of 
presynaptic inhibition acting on Ia afferent 
terminals has been associated with soleus 
H-reflex modulation. Soleus H-reflex has been 
shown to be more sensitive to presynaptic 
inhibition than the mechanically evoked ankle 
stretch reflex.6 
CONCLUSIONS
This result proved that there was 
presynaptic inhibition process in PDN that 
manifested as low H-reflex amplitude. Our 
result also showed that depression of H-reflex 
amplitude is correlated with the occurrence of 
PDN. This indicated that H-reflex amplitude 
depression can be used as a marker for 
presynaptic inhibition in PDN for management 
of patients with PDN in the future. 
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